CODHy 2027’s Program
2027 PROGRAM
May 22 Friday 2027
| 08:00-10:00 | Plenary Session 1: Opening Session Chair: 08:30-08:40 Chairs’ Opening Speech 08:40-09:00 Opening Ceremony Opening Report Chairs: 09:00-09:20 China’s Contribution to Global Diabetes Research 09:20-09:40 Is Curing Obesity and Diabetes a Realistic Goal? 09:40-10:00 The Brain as the Manager of Metabolic Disease |
| 10:00-12:00 | Plenary Session 2: Keynote Session Chairs: 10:00-10:20 Precision Diabetes Care: From Evidence to Personalized Treatment 10:20-10:40 Cardio-Renal-Metabolic Medicine: A Unified Paradigm 10:40-11:00 Cardiometabolic Risk Reduction: What the Trials Now Tell Us 11:00-11:20 Key Note Speaker Incretin Biology: From Discovery to the Multi-Agonist Era 11:20-11:40 Keynote Lecture — reserved for Chinese speaker (to be confirmed) 11:40-12:00 Hall Turnover and Lunch Box Pickup |
| HALL A | HALL B | HALL C | |
| 12:00-14:00 | Lunch Symposium A | Lunch Symposium B | Lunch Symposium C |
| 14:00-15:30 | Session 1 | AI & Digital Medicine Chairs: 14:00-14:15 AI and Digital Twins in Diabetes Care 14:15-14:30 CGM and Continuous Biological Monitoring 14:30-14:45 Digital Health Implementation in Asia 14:45-15:00 The Chinese AI Ecosystem in Diabetes 15:00-15:15 Real-World Evidence from Digital Platforms 15:15-15:30 Q&A and Panel Discussion | Session 2 | Incretin Biology & Obesity Science Chairs: 14:00-14:15 Triple Agonists and the Next Generation of Incretins 14:15-14:30 Obesity Pharmacotherapy: Real-World Evidence & Guidelines 14:30-14:45 Obesity & Metabolic Surgery: Where Do We Stand? 14:45-15:00 Incretin-Based Therapy in Chinese Patients 15:00-15:15 Weight Management in China: Clinical Experience 15:15-15:30 Q&A and Panel Discussion | Session 3 | Cardio-Renal-Metabolic Medicine Chairs: 14:00-14:15 The Future of Complication Prevention: Heart Failure 14:15-14:30 Kidney Protection in Diabetes 14:30-14:45 Precision Prevention of Cardiometabolic Disease 14:45-15:00 CKM Management in Chinese Patients 15:00-15:15 Cardio-Renal Outcomes: China Data 15:15-15:30 Q&A and Panel Discussion |
| 15:30-17:00 | Session 4 | Obesity, Brain & Behavior Chairs: 15:30-15:45 Obesity as a Chronic Metabolic Disease 15:45-16:00 Muscle Biology in Metabolic Health 16:00-16:15 Self-Control and Obesity: Neurological and Involuntary? 16:15-16:30 Stress, Cortisol, Visceral Fat & Mental Health 16:30-16:45 Sleep, Obesity and Metabolic Risk 16:45-17:00 Q&A and Panel Discussion | Session 5 | Liver, Gut & MASLD Chairs: 15:30-15:45 MASLD: From Mechanisms to Therapy 15:45-16:00 MASLD in Asian Patients 16:00-16:15 The Gut Microbiome in Obesity and Diabetes 16:15-16:30 MASLD in Chinese Patients: Clinical Practice 16:30-16:45 Precision Nutrition: Evidence-Based or Marketing? 16:45-17:00 Q&A and Panel Discussion | Session 6 | Disease Modification: Remission & Cell Therapy Chairs: 15:30-15:45 Beta-Cell Preservation and Disease Modification 15:45-16:00 Immunometabolism & Immune Modulation in T1D 16:00-16:15 T2D Remission in China: Real Healing or Temporary Repose? 16:15-16:30 Cell Therapy: China Progress 16:30-16:45 Beta-Cell Biology in Asian Young-Onset Diabetes 16:45-17:00 Q&A and Panel Discussion |
| 17:00-18:00 | CODHy Master Class Series Interactive Learning with World Leaders Divided into several private rooms, each dedicated to a different topic. |
May 23 SATURDAY 2026
| HALL A | HALL B | HALL C | |
| 08:30-10:10 | Session 7 | The Future of Diabetes Chairs: 08:30-08:50 The Future of Diabetes Care 08:50-09:10 Clinical Diabetes: Lessons from Recent Trials 09:10-09:30 China Meets the World: Diabetes Research 09:30-09:50 China’s Contribution to Global Diabetes Research 09:50-10:10 Q&A and Panel Discussion | Session 8 | Precision Medicine & Longevity Chairs: 08:30-08:50 Precision Medicine: Hype or Reality? 08:50-09:10 Cardiometabolic Health and Healthy Longevity 09:10-09:30 Precision Medicine in Chinese Populations 09:30-09:50 Genetics and Personalized Medicine in China 09:50-10:10 Q&A and Panel Discussion | Session 9 | Population Health & Real-World Evidence Chairs: 08:30-08:50 Population Health and Diabetes Prevention 08:50-09:10 Real-World Evidence & Guidelines 09:10-09:30 Young-Onset Type 2 Diabetes in China 09:30-09:50 Real-World Evidence from Chinese Cohorts 09:50-10:10 Q&A and Panel Discussion |
| 10:10-11:50 | Session 10 | Cardiometabolic Risk Chairs: 10:10-10:30 Cardiometabolic Risk: New Frontiers 10:30-10:50 Heart Failure Prevention in Diabetes 10:50-11:10 Hypertension in Metabolic Disease: China Perspective 11:10-11:30 Cardiometabolic Risk in Chinese Patients 11:30-11:50 Q&A and Panel Discussion | Session 11 | Young Scientist & Rising Star Session Five young scientists present their research — topics to be confirmed 10:10-10:30 Young Scientist Presentation 1 — to be confirmed (TBA) 10:30-10:50 Young Scientist Presentation 2 — to be confirmed 10:50-11:10 Young Scientist Presentation 3 — to be confirmed (TBA) 11:10-11:30 Young Scientist Presentation 4 — to be confirmed 11:30-11:50 Young Scientist Presentation 5 — to be confirmed (TBA) | Session 12 | Diabetic Foot & Limb Preservation Chairs: 10:10-10:30 The Future of Diabetic Foot Care 10:30-10:50 Limb Preservation and Podiatric Surgery 10:50-11:10 The Diabetic Foot in China: Current Situation 11:10-11:30 Diabetic Foot Management: Chinese Clinical Experience 11:30-11:50 Q&A and Panel Discussion |
11:50-12:00 12:00-14:00 | Lunch box Pickup Lunch Symposium D | Lunch box Pickup Lunch Symposium E | Lunch box Pickup Lunch Symposium F |
| 14:00-15:30 | Session 13 | Glycemic Variability & Technology Chairs: 14:00-14:15 Glycemic Variability: Why It Matters 14:15-14:30 CGM in the Era of AI 14:30-14:45 Technology-Enabled Care in Asia 14:45-15:00 Digital Therapeutics in China 15:00-15:15 CGM Implementation in Chinese Practice 15:15-15:30 Q&A and Panel Discussion | Session 14 | Muscle Biology & Frontiers in Biology Chairs: 14:00-14:15 Muscle as a Metabolic Organ 14:15-14:30 Inter-organ Metabolic Communication 14:30-14:45 Frontiers in Metabolic Biology (TBC) 14:45-15:00 Muscle Biology Research in China 15:00-15:15 Single-Cell Insights: China Studies 15:15-15:30 Q&A and Panel Discussion | Session 15 | Asia-Pacific Perspectives Chairs: 14:00-14:15 Diabetes in Asian Populations 14:15-14:30 Obesity in Asia 14:30-14:45 Diabetes Care in Southeast Asia 14:45-15:00 Diabetes in Chinese Populations 15:00-15:15 China’s Contribution to Asian Diabetes Research 15:15-15:30 Q&A and Panel Discussion |
| 15:30-17:00 | Session 16 | Clinical Diabetes & Mechanisms Chairs: 15:30-15:45 Clinical Diabetes: State of the Art 15:45-16:00 Mechanisms & Translational Science 16:00-16:15 Reducing Therapeutic Inertia 16:15-16:30 Clinical Diabetes Management in China 16:30-16:45 Translational Research from China 16:45-17:00 Q&A and Panel Discussion | Session 17 | Immunometabolism & Guideline Implementation Chairs: 15:30-15:45 Immunometabolism in Diabetes 15:45-16:00 Guideline Implementation Across Populations 16:00-16:15 Bridging Guidelines and Practice 16:15-16:30 Chinese Diabetes Guidelines: Implementation 16:30-16:45 Immunometabolism Research in China 16:45-17:00 Q&A and Panel Discussion | MMC Session 15:30-18:00 Reserved for MMC — no program scheduled. Room available until 18:00. |